Alzheimers

Aduhelm For Alzheimer’s: Who Should Get It? : Shots

As part of a clinical study, a patient with Alzheimer’s disease receives an infusion of aducanumab at a Providence, R.I., hospital in 2019. Aducanumab is being marketed as Aduhelm. Charles Krupa/AP hide caption toggle caption Charles Krupa/AP As part of…